MIR-2911 (Jiangsu Mingma Biological Technology)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameMIR-2911 (Jiangsu Mingma Biological Technology)
Drug Alias NamemicroRNA2911MIR-2911
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfluenza A virus infectionsCoronavirus Disease 2019 (COVID-19)Influenza in Birds +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Mingma Biological Technology Co LtdNanjing University
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Provincial Center For Disease Control And PreventionNanjing UniversityChinese Academy Of Agricultural Sciences +[4] 
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsCoronavirus Disease 2019 (COVID-19)Influenza in Birds +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A